Literature DB >> 12676512

Intracellular signal transduction pathways activated by ceramide and its metabolites.

Peter P Ruvolo1.   

Abstract

The sphingolipid ceramide has proven to be a powerful second-signal effector molecule that regulates diverse cellular processes including apoptosis, cell senescence, the cell cycle, and cellular differentiation. Ceramide has been shown to activate a number of enzymes involved in stress signaling cascades including both protein kinases and protein phosphatases. Ceramide kinase targets include stress-activated protein kinases (SAPKs) such as the jun kinases (JNKs), kinase suppressor of Ras (KSR), and the atypical protein kinase C (PKC) isoform, PKC zeta. Ceramide also is capable of activating protein phosphatases such as protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A). It is through these protein phosphatases that ceramide can indirectly inhibit kinases that are key components of pro-growth signaling processes such as the classical and novel PKC isoforms and protein kinase B (PKB; also known as Akt). However, the mechanisms how ceramide directly activates enzymes such as JNK and PP2A are still not clear. Elucidation of these mechanisms will reveal how ceramide functions in stress signaling cascades and will provide important information on cellular processes such as apoptosis. It is becoming clear that the ceramide generation is a near universal feature of programmed cell death. It is possible that during at least some apoptotic events, ceramide may be required to activate stress-signal cascades that lead to cell death, while concurrently, suppressing growth and survival pathways in the dying cell. Such a versatile role for ceramide is not unreasonable since ceramide has been implicated as having a role in both intrinsic (i.e. mitochondrial) and extrinsic (i.e. death receptor-mediated) apoptotic pathways. The recent data suggesting that aberrant glycosylation of ceramide (i.e. inactivation of the molecule) may be an important cause of drug resistance in certain cancers suggests that ceramide-mediated signaling cascades are critical components of chemotherapy-induced cell killing. Taken together, these properties of ceramide suggest that this important second-signal molecule may be an important target in anti-neoplastic strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676512     DOI: 10.1016/s1043-6618(03)00050-1

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  105 in total

1.  Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans.

Authors:  Harm J Bogaard; Shiro Mizuno; Christophe Guignabert; Aysar A Al Hussaini; Daniela Farkas; Gerrina Ruiter; Donatas Kraskauskas; Elie Fadel; Jeremy C Allegood; Marc Humbert; Anton Vonk Noordegraaf; Sarah Spiegel; Laszlo Farkas; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

2.  Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Edward Re; Lisa Longato; Ming Tong
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.

Authors:  Manshu Sui; Jin Zhou; Rujuan Xie; Xiaogang Liu; Suhong Mu; Xibei Jia; Jing Ma; Hongchi Wu
Journal:  Mol Biol Rep       Date:  2011-08-11       Impact factor: 2.316

4.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.

Authors:  Tejas S Tirodkar; Ping Lu; Aiping Bai; Matthew J Scheffel; Salih Gencer; Elizabeth Garrett-Mayer; Alicja Bielawska; Besim Ogretmen; Christina Voelkel-Johnson
Journal:  J Biol Chem       Date:  2015-04-03       Impact factor: 5.157

6.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

7.  Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.

Authors:  Xingming Deng; Fengqin Gao; W Stratford May
Journal:  Blood       Date:  2008-10-09       Impact factor: 22.113

8.  Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells.

Authors:  Nathan L Alderson; Hiroko Hama
Journal:  J Lipid Res       Date:  2009-01-22       Impact factor: 5.922

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

10.  Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action.

Authors:  Kristin Baetz; Lianne McHardy; Ken Gable; Tamsin Tarling; Delphine Rebérioux; Jenny Bryan; Raymond J Andersen; Teresa Dunn; Phil Hieter; Michel Roberge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.